SBL
MEDP icon

Sargent Bickham Lagudis’s Medpace MEDP Stock Holding History

Sargent Bickham Lagudis’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.19K Buy
+15
New +$3K ﹤0.01% 856

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sargent Bickham Lagudis's MEDP Position: Q4 2022 in Review

Sargent Bickham Lagudis opened a new position in Medpace (MEDP) in Q4 2022: 15 shares worth $3.19K. The stake represents ﹤0.01% of the portfolio and ranks #856 among its holdings.

422 funds tracked by Wall St. Rank hold MEDP as of Q4 2022.

  • Sargent Bickham Lagudis held 15 shares of Medpace worth $3.19K as of Q4 2022.
  • Medpace was a new Sargent Bickham Lagudis position in Q4 2022.
  • Medpace made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #856 holding.
  • 422 funds tracked by Wall St. Rank held Medpace as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.